Invention Grant
- Patent Title: Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
-
Application No.: US16491116Application Date: 2018-03-05
-
Publication No.: US11091505B2Publication Date: 2021-08-17
- Inventor: Christopher J. Burns , Daniel C. Pevear , Luigi Xerri , Timothy Henkel , Daniel McGarry , Lawrence Rosen , Gerald Brenner , Jean-Baptiste Arlin , Ana Fernandez Casares
- Applicant: VenatoRx Pharmaceuticals, Inc.
- Applicant Address: US PA Malvern
- Assignee: VenatoRx Pharmaceuticals, Inc.
- Current Assignee: VenatoRx Pharmaceuticals, Inc.
- Current Assignee Address: US PA Malvern
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/020968 WO 20180305
- International Announcement: WO2018/165048 WO 20180913
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61P31/04 ; A61K47/18 ; A61K47/12 ; A61K47/02 ; A61K47/26 ; A61K9/00 ; A61K31/546
Abstract:
Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.
Public/Granted literature
- US20200010485A1 SOLID FORMS AND COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF Public/Granted day:2020-01-09
Information query
